μ阿片受体激活是NMDA受体拮抗剂抗应激行为效应所必需的
研究使用长效μ阿片受体(MOR)选择性拮抗剂MCAM,探究MOR在(R,S)-氯胺酮及选择性NMDA受体拮抗剂FENM抗应激所致适应不良行为中的作用。结果显示,尽管(R,S)-氯胺酮及其对映体对MOR有弱部分激动作用而FENM直接MOR活性可忽略,但MCAM预处理均能阻断两者在应激前后给药的行为效应。结论提示MOR激活是两种NMDAR拮抗剂抗应激行为效应所必需的,可能通过内源性阿片信号间接介导。
要点
- (R,S)-氯胺酮及对映体对MOR呈弱部分激动,FENM的直接MOR活性可忽略。
- MCAM阻断(R,S)-氯胺酮和FENM在应激前后给药的行为效应。
- MOR激活是两种NMDAR拮抗剂抗应激适应不良行为所必需的。
核心结论
- MOR激活是(R,S)-氯胺酮和FENM对抗应激所致适应不良行为所必需的。
- 提示这些化合物通过NMDAR拮抗对内源性阿片信号的间接效应发挥作用。
研究设计与样本
- 使用长效MOR选择性拮抗剂MCAM,评估MOR在(R,S)-氯胺酮和FENM抗应激行为效应中的贡献。
- 采用细胞信号 assay 检测(R,S)-氯胺酮对映体、代谢物及FENM直接激活MOR的能力。
- 在多种行为范式中测试(R,S)-氯胺酮和FENM,并比较载体或MCAM预处理的影响。
- 使用膜片钳电生理确定MOR拮抗对(R,S)-氯胺酮给药后腹侧海马CA3谷氨酸能活动的影响。
主要发现
- (R,S)-氯胺酮及其对映体显示对MOR的弱部分激动作用,而FENM的效力和效能可忽略。
- (R,S)-氯胺酮的镇痛效应比FENM更强效且对MCAM阻断更敏感。
- 应激前或应激后给予(R,S)-氯胺酮或FENM均减少行为绝望。
- MCAM阻止了两种NMDAR拮抗剂在应激前或应激后给药的行为效应,尽管其直接MOR活性和镇痛作用存在差异。
临床怎么用
- 提示MOR激活可能是NMDAR拮抗剂抗应激相关行为效应的必要条件。
- 联合MOR拮抗剂可能削弱氯胺酮类药物的抗应激行为疗效,临床用药时需考虑阿片受体状态。
局限性
- 原文未明确报告研究样本量、物种及具体行为范式细节。
- 结论主要基于动物行为与电生理实验,向临床转化需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contradictory evidence has emerged regarding the role of the mu opioid receptor (MOR) in the antidepressant actions of (R,S)-ketamine. METHODS: Here, we used the long-acting MOR-selective antagonist methocinnamox (MCAM) to determine the contribution of MOR to the actions of (R,S)-ketamine and the more selective NMDA receptor (NMDAR) antagonist fluoroethylnormemantine (FENM) against stress-induced maladaptive behaviors. (R,S)-ketamine enantiomers and metabolites and FENM were assessed for their ability to directly activate MOR in cell signaling assays. (R,S)-ketamine and FENM were tested in various behavioral paradigms with vehicle or MCAM pretreatment. Patch clamp electrophysiology was used to determine the effects of MOR antagonism on ventral hippocampal CA3 glutamatergic activity after (R,S)-ketamine administration. RESULTS: (R,S)-ketamine and its enantiomers showed weak partial agonism of MOR, whereas the potency and efficacy of FENM were negligible. The antinociceptive effect of (R,S)-ketamine was both more potent and more sensitive to blockade by MCAM than that of FENM. When given either before or after stress, both (R,S)-ketamine and FENM reduced behavioral despair. MCAM prevented the effects of both NMDAR antagonists given before or after stress, despite their differences in direct MOR activity and antinociception. CONCLUSIONS: MOR activation is required for the efficacy of both (R,S)-ketamine and FENM against stress-induced maladaptive behavior, suggesting that these compounds function through an indirect effect of NMDAR antagonism on endogenous opioid signaling.
引用
- Langreck CB, Chen BK, Luna VM, et al. Mu Opioid Receptor Activation Is Required for NMDA Receptor Antagonist Effects on Stress-Induced Maladaptive Behavior. Biol Psychiatry. 2025. PMID: 40633884. doi:10.1016/j.biopsych.2025.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。